Aeterna Wealth

Mutual funds holding Glenmark Pharmaceuticals shares

116 mutual fund schemes held Glenmark Pharmaceuticals shares in their latest portfolios (October 2026, or September 2026 where a fund house's October 2026 portfolio is not yet in), worth about ₹8,124 cr in all. The largest holders by value are HDFC Mid Cap Fund (3.1% of the fund), Invesco India Mid Cap Fund (2.7% of the fund), Invesco India Contra Fund (2.0% of the fund).

Against the month before, 1 scheme added Glenmark Pharmaceuticals as a new holding and 1 sold out of it completely.

New holders: HDFC MNC Fund

Sold out: quant Consumption Fund

By category: Index Fund (56), Sectoral/Thematic (21), Large & Mid Cap (8), Arbitrage (8), Mid Cap (4), Multi Cap (4).

9 actively managed schemes holding it are rated A+ or A on their track record, among them Invesco India Mid Cap Fund, Invesco India Contra Fund, Quant ELSS Tax Saver Fund, Invesco India Large & Mid Cap Fund, HDFC Balanced Advantage Fund.

Every scheme holding Glenmark Pharmaceuticals, by value

SchemeRating% of fundValueChange
HDFC Mid Cap FundMid CapC3.06%₹3,081 cr-0.01
Invesco India Mid Cap FundMid CapA+2.66%₹421 cr-0.10
Invesco India Contra FundValue / ContraA+2.03%₹390 cr-0.03
Quant ELSS Tax Saver FundELSSA2.73%₹351 cr+2.08
Invesco India Large & Mid Cap FundLarge & Mid CapA+2.17%₹270 cr-0.40
Quant Flexi Cap FundFlexi CapB3.46%₹249 cr+0.02
Quant Multi Cap FundMulti CapC3.41%₹248 cr+0.99
HDFC Large & Mid Cap FundLarge & Mid CapC0.86%₹242 cr+0.00
SBI Arbitrage FundArbitrageA+0.46%₹212 cr–
HDFC Balanced Advantage FundBalanced AdvantageA0.20%₹203 cr–
Mirae Asset Healthcare FundSectoral/ThematicB4.61%₹164 cr-0.17
Nippon India Arbitrage FundArbitrageB0.78%₹141 cr–
Tata Mid Cap FundMid CapB2.39%₹137 cr–
Quant Large & Mid Cap FundLarge & Mid CapB3.94%₹133 cr-0.04
UTI Nifty 200 Momentum 30 Index FundIndex FundA1.75%₹133 cr–
HDFC Manufacturing FundSectoral/Thematic–1.36%₹132 cr+0.05
Mahindra Manulife Mid Cap FundMid CapB2.65%₹130 cr–
UTI Value FundValue / ContraB1.09%₹98 cr–
Axis Multicap FundMulti CapA+0.75%₹92 cr–
HDFC Arbitrage FundArbitrageA0.32%₹83 cr–
Axis Large & Mid Cap FundLarge & Mid CapB0.46%₹75 cr–
HDFC Pharma and Healthcare FundSectoral/ThematicA+1.96%₹72 cr-0.13
Mahindra Manulife Multi Cap FundMulti CapB0.96%₹70 cr–
Mahindra Manulife Small Cap FundSmall CapA+1.28%₹66 cr–
Mahindra Manulife Large & Mid Cap FundLarge & Mid CapB2.24%₹61 cr–
Aditya Birla Sun Life Quant FundSectoral/Thematic–3.03%₹56 cr–
DSP Arbitrage fundArbitrageB0.69%₹48 cr–
quant Healthcare FundSectoral/ThematicB9.38%₹39 cr+0.04
Edelweiss Nifty Midcap150 Momentum 50 Index FundIndex FundB2.15%₹36 cr–
UTI Large & Mid Cap FundLarge & Mid CapB0.57%₹35 cr–
Motilal Oswal Nifty Midcap 150 Index FundIndex FundB0.89%₹35 cr+0.02
Bank Of India Aggressive Hybrid FundAggressive HybridA1.54%₹34 cr–
Baroda BNP Paribas Arbitrage FundArbitrageC3.15%₹32 cr–
UTI - Healthcare FundSectoral/ThematicB2.12%₹30 cr–
Edelweiss Business Cycle FundSectoral/Thematic–2.17%₹28 cr–
Axis India Manufacturing FundSectoral/Thematic–0.50%₹27 cr–
Tata Nifty Midcap 150 Momentum 50 Index FundIndex FundB2.15%₹26 cr–
Nippon India Nifty Midcap 150 Index FundIndex FundB0.89%₹23 cr+0.02
Invesco India Pharma and Healthcare FundSectoral/Thematic–4.48%₹21 cr-0.38
Nippon India Nifty 500 Momentum 50 Index FundIndex FundA1.67%₹21 cr+0.02

And 76 more schemes with smaller holdings.

Value: the scheme's assets under management × the stock's weight, approximate. Change: the weight against the previous month's portfolio, in percentage points; it moves with the share price as well as with buying and selling. Links go to each scheme's Regular plan.

Common questions

How many mutual funds hold Glenmark Pharmaceuticals shares?

116 schemes held Glenmark Pharmaceuticals in their latest monthly portfolios (October 2026, or September 2026 where a fund house's October 2026 portfolio is not yet in), worth about ₹8,124 cr in all.

Which mutual fund holds the most Glenmark Pharmaceuticals shares?

By value, HDFC Mid Cap Fund: about ₹3,081 cr, 3.06% of the fund.

Where does this data come from?

From the monthly portfolios that every fund house must publish by the 10th of the following month. Values are approximate: the fund's assets under management multiplied by the stock's weight in the portfolio.

This page lists which funds hold a stock. It is not a view on the stock or a recommendation to buy or sell it or any fund. Ratings describe past track records, not a forecast.

Free portfolio review

Send us your CAS and get a written report: which of your funds to keep, which to exit and when, where new SIPs should go, and what each change costs in tax.

Chat with us